drugset / Trial / NCT02949310

Effectiveness of Nefopam in Breast Cancer Surgery

NCT02949310

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Breast cancer surgery is known to cause severe acute postoperative pain, which can persist for a long time. The investigators administered nefopam preventively to patients undergoing total mastectomy or modified radical mastectomy with axillary lymph node dissection or sentinel lymph node biopsy, and evaluated its efficacy on acute and chronic postoperative pain.

Timeline

Start
2016-10
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nefopam Small molecule 40 mg

Indications